We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current COLL market cap is 1.06B. The company's latest EPS is USD 1.5067 and P/E is 22.11.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 144.77M | 135.55M | 136.71M | 149.75M | 144.92M |
| Operating Income | 24.63M | 35.63M | 45.01M | 61.69M | 49.47M |
| Net Income | -17.43M | 13.01M | 20.63M | 31.94M | 27.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 296.7M | 310.02M | 276.87M | 463.93M | 566.77M |
| Operating Income | -23.75M | 56.23M | 17.63M | 33.32M | 166.96M |
| Net Income | -22.72M | 26.75M | 71.52M | -25M | 48.16M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.21B | 1.21B | 1.18B | 1.14B | 1.11B |
| Total Liabilities | 1.03B | 1.01B | 998.71M | 947.88M | 892.08M |
| Total Equity | 179.73M | 200.81M | 178.87M | 195.43M | 222.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 306.3M | 643.84M | 692.08M | 1.17B | 1.14B |
| Total Liabilities | 218.87M | 457.81M | 489.15M | 979.29M | 947.88M |
| Total Equity | 87.43M | 186.03M | 202.93M | 194.84M | 195.43M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 27.67M | 127.39M | 201.41M | 274.75M | 61.94M |
| Investing | -176k | -41.89M | -45.72M | -70.81M | -18.13M |
| Financing | 68.3M | 23.06M | -72.35M | -140.18M | -54.15M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 27.78M | 93.94M | 103.56M | 124.23M | 274.75M |
| Investing | -6.44M | -373.77M | -1.94M | -573.69M | -70.81M |
| Financing | 2.04M | 286.47M | -89.3M | 436.72M | -140.18M |
| Market Cap | 1.06B |
| Price to Earnings Ratio | 22.11 |
| Price to Sales Ratio | 1.88 |
| Price to Cash Ratio | 4.46 |
| Price to Book Ratio | 5.45 |
| Dividend Yield | - |
| Shares Outstanding | 31.96M |
| Average Volume (1 week) | 574.2k |
| Average Volume (1 Month) | 519.45k |
| 52 Week Change | 52.73% |
| 52 Week High | 40.95 |
| 52 Week Low | 20.83 |
| Spread (Intraday) | 2.11 (6.24%) |
| Company Name | Collegium Pharmaceutical Inc |
| Address |
100 shockoe slip richmond, virginia 23219 4100 |
| Website | https://www.collegiumpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
